NMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nomura Holdings Inc (NMR) does not present a strong buy opportunity at the moment for a beginner investor with a long-term strategy. While the technical indicators show some bullish signals, the financial performance and recent news do not strongly support a compelling entry point. The lack of significant positive catalysts and the neutral sentiment from hedge funds and insiders further suggest holding off on investment for now.
The MACD histogram is positive at 0.00863, indicating a bullish trend, but it is contracting. RSI is neutral at 39.722, showing no clear signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 8.227, and resistance is at 8.682. The stock has a 70% chance to decline by -1.62% in the next day but shows a potential 10.02% gain over the next month.
Analyst upgrade from JPMorgan to Overweight with a higher price target of 1,440 yen, citing the strength of the company's core business.
Q1 financial results show a decline in net income (-10.73% YoY) and EPS (-9.09% YoY). The company did not provide earnings forecasts due to market uncertainties, which may indicate caution. Insider and hedge fund trading sentiment is neutral.
In Q3 2026, revenue increased by 1.39% YoY, but net income dropped by 10.73% YoY, and EPS fell by 9.09% YoY. Gross margin improved by 7.23% YoY to 44.93%.
JPMorgan upgraded the stock to Overweight from Neutral with a price target increase from 1,430 yen to 1,440 yen, citing undervaluation and strong core business performance.
